Fresenius closing book on $4.2bn refi with IG-like pricing
Fresenius Medical Care, the US subsidiary of Fresenius SE, is closing books on a $4.2bn refinancing loan today, offering margins at a level more familiar to investment grade borrowers than double-B credits like Fresenius.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts